Related Experiment Video
Updated: Jan 4, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
Stuart J Pocock1, David Brieger2, John Gregson1
1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Insights
A new risk index helps predict long-term cardiovascular events and death in patients with stable coronary artery disease after myocardial infarction (MI). This tool stratifies risk, aiding clinical management for improved patient outcomes.
Area of Science:
- Cardiology
- Clinical Risk Prediction
- Public Health
Background:
- Lack of risk prediction tools for patients with stable disease years after myocardial infarction (MI).
- Need for practical long-term cardiovascular risk assessment in post-MI patients.
Purpose of the Study:
- To develop a practical long-term cardiovascular risk index for stable patients post-MI.
- To identify key predictors of adverse cardiovascular events and death in this population.
Main Methods:
- Prospective global registry (1-3 years post-MI) including 9027 patients with at least one risk factor.
- Utilized multivariable Poisson regression to identify predictors of a composite outcome (MI, unstable angina, stroke, death) over 2 years.
- Developed and validated a user-friendly risk index.
Main Results:
- The primary composite outcome occurred in 6.9% of patients over 2 years, with events accruing linearly.
- Identified 11 significant predictors including age, diabetes, CKD, heart failure, and poor self-reported health.
- The risk index demonstrated good discriminative ability (c-statistic 0.686-0.849) in derivation and validation cohorts.
Conclusions:
- Recurrent cardiovascular events and deaths accumulate linearly in patients more than 1 year post-MI.
- A simple, validated risk index can effectively stratify patients.
- This index may assist clinicians in guiding long-term management strategies for stable post-MI patients.
Background:
Risk prediction tools are lacking for patients with stable disease some years after myocardial infarction (MI).
Hypothesis:
A practical long-term cardiovascular risk index can be developed.
Methods:
The long-Term rIsk, Clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients prospective global registry enrolled patients 1 to 3 years post-MI (369 centers; 25 countries), all with ≥1 risk factor (age ≥65 years, diabetes mellitus requiring medication, second prior MI, multivessel coronary artery disease, or chronic non-end-stage kidney disease [CKD]). Self-reported health was assessed with EuroQoL-5 dimensions. Multivariable Poisson regression models were used to determine key predictors of the primary composite outcome (MI, unstable angina with urgent revascularization [UA], stroke, or all-cause death) over 2 years.
Results:
The primary outcome occurred in 621 (6.9%) of 9027 eligible patients: death 295 (3.3%), MI 195 (2.2%), UA 103 (1.1%), and stroke 58 (0.6%). All events accrued linearly. In a multivariable model, 11 significant predictors of primary outcome (age ≥65 years, diabetes, second prior MI, CKD, history of major bleed, peripheral arterial disease, heart failure, cardiovascular hospitalization (prior 6 months), medical management (index MI), on diuretic, and poor self-reported health) were identified and combined into a user-friendly risk index. Compared with lowest-risk patients, those in the top 16% had a rate ratio of 6.9 for the primary composite, and 18.7 for all-cause death (overall c-statistic; 0.686, and 0.768, respectively). External validation was performed using the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events registry (c-statistic; 0.748, and 0.849, respectively).
Conclusions:
In patients >1-year post-MI, recurrent cardiovascular events and deaths accrue linearly. A simple risk index can stratify patients, potentially helping to guide management.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction